Hospira Gemcitabine Injection (38 mg/mL) 200 mg/5.26 mL (US)

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

gemcitabine hydrochloride, Quantity: 43.27 mg/mL; water for injections

Disponibbli minn:

Hospira Australia Pty Ltd

INN (Isem Internazzjonali):

Gemcitabine hydrochloride,water for injections

Għamla farmaċewtika:

Injection, solution

Kompożizzjoni:

Excipient Ingredients: sodium hydroxide; hydrochloric acid

Rotta amministrattiva:

Intravenous Infusion

Unitajiet fil-pakkett:

1 x 5.26 mL pack

Klassi:

Medicine Listed (Export Only)

Tip ta 'preskrizzjoni:

(S1) This Schedule is intentionally blank

Indikazzjonijiet terapewtiċi:

Ovarian cancer, breast cancer, non small cell lung cancer, pancreatic cancer

Sommarju tal-prodott:

Visual Identification: A clear, colourless or light straw coloured solution practically free from visible particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2011-11-04